Please Wait.....
Report
US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-06-14 I 135 Pages I IMARC Group
Market Overview:
The US generic injectables market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.7 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.
A generic injectable refers to a bioequivalent of the branded pharmaceutical needle with the same active ingredients and therapeutic effects. It has similar dosage, risks, side effects, consequences, performance, strengths, intended use, and route of administration. It is as safe and effective as the innovator drugs and used for rapidly transporting the drug into the body. It helps in the easy absorption of drugs into the body and reduces the frequency of dosage administration without affecting the effectiveness of the treatment. Besides this, it is cost-effective and does not require investments in testing, research and development (R&D), and promotional activities as compared to its branded counterparts. As a result, generic injectables are utilized in the treatment of various diseases, such as cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, and respiratory and cardiovascular disorders.
US Generic Injectable Market Trends:
The growing geriatric population and the rising prevalence of chronic medical ailments, such as diabetes, cancer, and cardiovascular diseases, represent one of the key factors increasing the need for generic injectables in the US. In addition, the growing occurrence of lifestyle disorders due to changing dietary patterns and sedentary lifestyles of individuals is positively influencing the market. In line with this, various initiatives undertaken by the US government for providing support to key manufacturers and sellers are offering a favorable market outlook. This, in confluence with the low production cost of generic medicines, is contributing to the market growth. Furthermore, the expansion of offline pharmacies in the country, along with the easy availability of generic injectables via online pharmacies and the patent expiration of several branded injectables, are offering lucrative growth opportunities to generic injectables manufacturers. Additionally, drug shortages in the country, coupled with speedy approvals by the United States Food and Drug Administration (USFDA), are increasing the manufacturing of these injectables. Apart from this, rising investments by leading market players in research and development (R&D) activities for developing advanced generic injectables are creating a positive market outlook. Moreover, the widespread adoption of advanced technologies in the manufacturing process of generic injectables is propelling the market growth in the US.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the US generic injectables market report, along with forecasts at the country and regional level from 2023-2028. Our report has categorized the market based on therapeutic area, containers, and distribution channel.
Breakup by Therapeutic Area:
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular
On the basis of the therapeutic area, the market has been segmented into oncology, anesthesia, anti-infectives, parenteral nutrition, and cardiovascular.
Breakup by Containers:
Vials
Ampoules
Premix
Prefilled Syringes
Based on the containers, the market has been bifurcated into vials, ampoules, premix, and prefilled syringes.
Breakup by Distribution Channel:
Hospitals
Retail Pharmacy
On the basis of the distribution channel, the market has been classified into hospitals and retail pharmacies.
Competitive Landscape:
The market is highly concentrated in nature with the presence of only a few top manufacturers who compete against one another in terms of prices and quality.
Key Questions Answered in This Report:
What was the size of the US generic injectables market in 2022?
What is the expected growth rate of the US generic injectables market during 2023-2028?
What has been the impact of COVID-19 on the US generic injectables market?
What are the key factors driving the US generic injectables market?
What is the breakup of the US generic injectables market based on the therapeutic area?
What is the breakup of the US generic injectables market based on the containers?
What is the breakup of the US generic injectables market based on the distribution channel?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.2.1 Sales Volume
5.2.2 Sales Value
5.3 Market Breakup by Country
5.4 Market Forecast
6 US Generic Drug Industry
6.1 Market Overview
6.2 Market Performance
6.2.1 Sales Volume
6.2.2 Sales Value
6.3 Market Forecast
7 US Generic Drug Industry - Drug Delivery Systems
7.1 Orals
7.2 Injectables
7.3 Dermal/Topical
7.4 Inhalers
8 Global Generic Injectables Industry
8.1 Market Overview
8.2 Market Performance
8.3 Market Breakup by Region
8.4 Market Breakup by Therapeutic Area
8.5 Market Breakup by Containers
8.6 Market Breakup by Distribution Channel
8.7 Market Share of Key Players
8.8 Market Forecast
9 US Generic Injectables Industry
9.1 Market Overview
9.2 Market Performance
9.3 Impact of COVID-19
9.4 Market by Therapeutic Area
9.5 Market by Containers
9.6 Market by Distribution Channel
9.7 Market Share of Key Players
9.8 Market Forecast
9.9 SWOT Analysis
9.9.1 Overview
9.9.2 Strengths
9.9.3 Weaknesses
9.9.4 Opportunities
9.9.5 Threats
9.10 Value Chain Analysis
9.11 Porters Five Forces Analysis
9.11.1 Overview
9.11.2 Bargaining Power of Buyers
9.11.3 Bargaining Power of Suppliers
9.11.4 Degree of Rivalry
9.11.5 Threat of New Entrants
9.11.6 Threat of Substitutes
9.12 Key Success and Risk Factors
10 US Generic Injectables Market: Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Anesthesia
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Anti-Infectives
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Parenteral Nutrition
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Cardiovascular
10.5.1 Market Trends
10.5.2 Market Forecast
11 US Generic Injectables Market: Breakup by Containers
11.1 Vials
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ampoules
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Premix
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Prefilled Syringes
11.4.1 Market Trends
11.4.2 Market Forecast
12 US Generic Injectables Market: Breakup by Distribution Channel
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Retail Pharmacy
12.2.1 Market Trends
12.2.2 Market Forecast
13 US Generic Injectables Market: Competitive Landscape
13.1 Competitive Structure
13.2 Market Breakup by Key Players
14 Generic Injectables Manufacturing Process
14.1 Product Overview
14.2 Detailed Process Flow
14.3 Various Types of Unit Operations Involved
14.4 Mass Balance and Raw Material Requirements
15 Project Details, Requirements and Costs Involved
15.1 Land, Location and Site Development
15.2 Construction Requirements
15.3 Machinery Requirements
15.4 Machinery Pictures
15.5 Raw Materials Requirements
15.6 Raw Material and Final Product Pictures
15.7 Packaging Requirements
15.8 Transportation Requirements
15.9 Product Pricing and Margins Across Various Levels of the Supply Chain
16 Key Player Profiles
Figure 1: Global: Generic Drug Market: Sale Volume (in Billion Standard Units), 2017-2022
Figure 2: Global: Generic Drug Market: Sale Value (in Billion US$), 2017-2022
Figure 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2022
Figure 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2022
Figure 5: Global: Generic Drug Market Forecast: Sale Volume (in Billion Standard Units), 2023-2028
Figure 6: Global: Generic Drug Market Forecast: Sale Value (in Billion US$), 2023-2028
Figure 7: US: Generic Drug Market: Sale Volume (in Billion Standard Units), 2017-2022
Figure 8: US: Generic Drug Market: Sale Value (in Billion US$), 2017-2022
Figure 9: US: Generic Drug Market Forecast: Sale Volume (in Billion Standard Units), 2023-2028
Figure 10: US: Generic Drug Market Forecast: Sale Value (in Billion US$), 2023-2028
Figure 11: US: Generic Drug Market: Drug Delivery Systems (in %), 2022
Figure 12: Global: Generic Injectables Market: Sale Value (in Billion US$), 2017-2022
Figure 13: Global: Generic Injectables Market: Breakup by Region (in %), 2022
Figure 14: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 15: Global: Generic Injectables Market: Breakup by Containers (in %), 2022
Figure 16: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 17: Global: Generic Injectables Market: Share of Key Players (in %), 2022
Figure 18: Global: Generic Injectables Market Forecast: Sale Value (in Billion US$), 2023-2028
Figure 19: US: Generic Injectables Market: Sale Value (in Billion US$), 2017-2022
Figure 20: US: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 21: US: Generic Injectables Market: Breakup by Containers (in %), 2022
Figure 22: US: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 23: US: Generic Injectables Market: Breakup by Key Players (in %), 2022
Figure 24: US: Generic Injectables Market Forecast: Sale Value (in Billion US$), 2023-2028
Figure 25: US: Generic Injectables Industry: SWOT Analysis
Figure 26: US: Generic Injectables Industry: Value Chain Analysis
Figure 27: US: Generic Injectables Industry: Porter's Five Forces Analysis
Figure 28: US: Generic Injectables (Oncology) Market: Sale Value (in Million US$), 2017 & 2022
Figure 29: US: Generic Injectables (Oncology) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 30: US: Generic Injectables (Anesthesia) Market: Sale Value (in Million US$), 2017 & 2022
Figure 31: US: Generic Injectables (Anesthesia) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 32: US: Generic Injectables (Anti-Infectives) Market: Sale Value (in Million US$), 2017 & 2022
Figure 33: US: Generic Injectables (Anti-Infectives) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 34: US: Generic Injectables (Parenteral Nutrition) Market: Sale Value (in Million US$), 2017 & 2022
Figure 35: US: Generic Injectables (Parenteral Nutrition) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 36: US: Generic Injectables (Cardiovascular) Market: Sale Value (in Million US$), 2017 & 2022
Figure 37: US: Generic Injectables (Cardiovascular) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 38: US: Generic Injectables (Vials) Market: Sale Value (in Million US$), 2017 & 2022
Figure 39: US: Generic Injectables (Vials) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 40: US: Generic Injectables (Ampoules) Market: Sale Value (in Million US$), 2017 & 2022
Figure 41: US: Generic Injectables (Ampoules) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 42: US: Generic Injectables (Premix) Market: Sale Value (in Million US$), 2017 & 2022
Figure 43: US: Generic Injectables (Premix) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 44: US: Generic Injectables (Prefilled Syringes) Market: Sale Value (in Million US$), 2017 & 2022
Figure 45: US: Generic Injectables (Prefilled Syringes) Market Forecast: Sale Value (in Million US$), 2023-2028
Figure 46: US: Generic Injectables Market: Sales through Hospitals (in Million US$), 2017 & 2022
Figure 47: US: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2023-2028
Figure 48: US: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2017 & 2022
Figure 49: US: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2023-2028
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing Process: Conversion Rate of Feedstock
Figure 52: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 53: Generic Injectables Manufacturing: Profit Margins at Various Levels of the Supply Chain
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 2: US: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 3: Global: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 4: US: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 5: US: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 6: US: Generic Injectables Market Forecast: Breakup by Containers (in Million US$), 2023-2028
Table 7: US: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 8: US: Generic Injectables Market: Competitive Structure
Table 9: US: Generic Injectables Market: Key Players
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Civil Works
Table 12: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit
Table 13: Generic Injectables Manufacturing Plant: Raw Material Requirements
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security